JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.02B |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$3.55B |
| 3 |
Eli Lilly
LLY
|
+$2.61B |
| 4 |
Amphenol
APH
|
+$2.33B |
| 5 |
TotalEnergies
TTE
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$9.67B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$7.48B |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.25B |
| 4 |
NVIDIA
NVDA
|
+$6.05B |
| 5 |
Microsoft
MSFT
|
+$5.54B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Miscellaneous | 24.97% |
| 3 | Financials | 9.75% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Healthcare | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PMT
2526
PennyMac Mortgage Investment
PMT
$683M
| $11M | ﹤0.01% |
873,470
+522,839
| +149% | +$6.52M |
2017 Q4
32 quarters
|
|
2527
MasterBrand
MBC
$1.44B
| $11M | ﹤0.01% |
992,263
+297,135
| +43% | +$3.48M |
2022 Q4
12 quarters
|
|
2528
Oscar Health
OSCR
$9.52B
| $10.9M | ﹤0.01% |
761,949
-1,714,696
| -69% | -$29.7M |
2021 Q2
18 quarters
|
|
2529
Cal-Maine
CALM
$3.06B
| $10.9M | ﹤0.01% |
137,547
-195,998
| -59% | -$17.2M |
2013 Q2
50 quarters
|
|
2530
Samsara
IOT
$24B
| $10.9M | ﹤0.01% |
308,414
-1,356,274
| -81% | -$52.5M |
2022 Q1
15 quarters
|
|
2531
Pagaya Technologies
PGY
$1.5B
| $10.9M | ﹤0.01% |
521,452
-531,249
| -50% | -$13.5M |
2024 Q2
6 quarters
|
|
|
CGAU
2532
Centerra Gold
CGAU
$4.18B
| $10.9M | ﹤0.01% |
756,438
-610,734
| -45% | -$7.64M |
2021 Q2
18 quarters
|
|
2533
CALL
Match Group
MTCH
$9.28B
| $10.9M | ﹤0.01% |
336,100
+48,400
| +17% | +$1.59M |
2023 Q3
9 quarters
|
|
2534
ZTO Express
ZTO
$14.6B
| $10.8M | ﹤0.01% |
517,484
+9,332
| +2% | +$185K |
2016 Q4
36 quarters
|
|
2535
NBT Bancorp
NBTB
$2.65B
| $10.8M | ﹤0.01% |
259,722
-75,191
| -22% | -$3.13M |
2013 Q2
50 quarters
|
|
2536
Establishment Labs
ESTA
$1.89B
| $10.7M | ﹤0.01% |
147,439
+28,855
| +24% | +$1.74M |
2021 Q2
18 quarters
|
|
2537
BioNTech
BNTX
$24.3B
| $10.7M | ﹤0.01% |
112,697
+52,541
| +87% | +$5.29M |
2020 Q1
23 quarters
|
|
2538
Fidelity MSCI Financials Index ETF
FNCL
$2.23B
| $10.7M | ﹤0.01% |
137,856
-3,462
| -2% | -$262K |
2017 Q1
35 quarters
|
|
|
2539
PUT
Oscar Health
OSCR
$9.52B
| $10.7M | ﹤0.01% |
745,000
+400,000
| +116% | +$6.92M |
2025 Q2
2 quarters
|
|
2540
Ligand Pharmaceuticals
LGND
$6.12B
| $10.7M | ﹤0.01% |
56,590
+16,872
| +42% | +$3.24M |
2015 Q4
40 quarters
|
|
2541
Centrus Energy
LEU
$2.88B
| $10.7M | ﹤0.01% |
44,052
+9,298
| +27% | +$2.81M |
2021 Q2
18 quarters
|
|
2542
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$11B
| $10.7M | ﹤0.01% |
354,000
+42,300
| +14% | +$1.28M |
2014 Q2
46 quarters
|
|
|
OPLN
2543
Openlane
OPLN
$4.34B
| $10.7M | ﹤0.01% |
358,067
-90,194
| -20% | -$2.44M |
2013 Q2
50 quarters
|
|
2544
Capricor Therapeutics
CAPR
$517M
| $10.7M | ﹤0.01% |
369,134
+179,335
| +94% | +$2.34M |
2024 Q1
7 quarters
|
|
2545
Harley-Davidson
HOG
$2.57B
| $10.7M | ﹤0.01% |
519,853
+81,285
| +19% | +$2M |
2013 Q2
50 quarters
|
|
2546
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$568M
| $10.6M | ﹤0.01% |
243,113
-42,813
| -15% | -$1.85M |
2014 Q4
44 quarters
|
|
|
BKV
2547
BKV Corp
BKV
$2.36B
| $10.6M | ﹤0.01% |
391,359
+249,911
| +177% | +$6.28M |
2024 Q4
4 quarters
|
|
|
BBNX
2548
Beta Bionics
BBNX
$1.02B
| $10.6M | ﹤0.01% |
348,671
+142,716
| +69% | +$3.81M |
2025 Q1
3 quarters
|
|
|
INGM
2549
Ingram Micro Holding
INGM
$6.49B
| $10.6M | ﹤0.01% |
497,536
-1,600,400
| -76% | -$34.7M |
2024 Q4
4 quarters
|
|
|
TBIL
2550
F/m US Treasury 3 Month Bill Fund
TBIL
$7.37B
| $10.6M | ﹤0.01% |
212,606
-52,507
| -20% | -$2.62M |
2025 Q1
3 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2025 Portfolio in Review
As of Q4 2025, JP Morgan Chase held 7,944 positions worth $1.59T, down 4.6% from $1.67T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
JP Morgan Chase withdrew a net $106B in Q4 2025, closing 563 positions and reducing 3,329 holdings. Its most notable exit was Interpublic Group of Companies, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, JP Morgan Chase opened a new position in Quadratic Interest Rate Volatility and Inflation Hedge ETF worth $99.9M.
- JP Morgan Chase's largest Q4 2025 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 5,216,227 shares worth $99.9M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2025, an estimated $4.02B increase.
- JP Morgan Chase's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $9.67B.
- JP Morgan Chase fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $228M.
- JP Morgan Chase's ten largest holdings make up 26% of its $1.59T portfolio in Q4 2025.
- JP Morgan Chase opened 577 new positions and closed 563 in Q4 2025.
- JP Morgan Chase's portfolio value fell 4.6% quarter-over-quarter to $1.59T.
Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.